نتایج جستجو برای: glibenclamide

تعداد نتایج: 2570  

Journal: :avicenna journal of phytomedicine 0
mostafa kazemian mansur abad department of biology, faculty of science, university of qom, qom, iran mohammad reza haeri department of clinical biochemistry, faculty of medicine, qom university of medical sciences, qom, iran mansoor ebrahimi department of biology, faculty of science, university of qom, qom, iran reza heidari anesthesiology section, qom university of medical sciences, qom, iran

objective: diabetes mellitus is the most common metabolic disorders with severe impact on quality of life. reducing serum glucose levels and normalization of serum lipid is of great clinical importance for treating diabetes. to our knowledge, there are not any evidences about the anti-diabetic action of capparis spinosa root. in the present study the effects of the c. spinosa root extract on di...

Journal: :iranian journal of diabetes and obesity 0
hakimeh ahadian department of oral medicine, shahid sadoughi university of medical science, yazd, iran samira hajimaghsoodi department of oral medicine, shahid sadoughi university of medical science, yazd, iran mohammad afkhami-ardekani yazd diabetes research center, shahid sadoughi university of medical science, yazd, iran

objective: this study aimed to estimate the prevalence of lichenoid reactions to anti hyperglycemic agents. materials and methods: in this cross-sectional descriptive and analytic study, we examined the oral mucosa of 411 patients at the age of 29 to 85 in 3 groups who consumed various antihyperglycemic agents. results: in overall, 31 patients had lichenoid reactions (12 patients taking glibenc...

Journal: :Fundamental & clinical pharmacology 2013
Elham A Afify Mohamed M Khedr Amal G Omar Suzanne A Nasser

This study investigated the role of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain. The K(ATP) channel modulators (K(ATP) channel opener, diazoxide 100 mg/kg, p.o, and K(ATP) channel blocker, glibenclamide, 3 mg/kg i.p.) were administered with morphine (80 mg/kg, i.p.). Antinociception was assessed by the tail-flick and formalin t...

2016
Ingmar Lundquist Israa Mohammed Al-Amily Sandra Meidute Abaraviciene Albert Salehi

Metformin lowers diabetic blood glucose primarily by reducing hepatic gluconeogenesis and increasing peripheral glucose uptake. However, possible effects by metformin on beta-cell function are incompletely understood. We speculated that metformin might positively influence insulin secretion through impacting the beta-cell nitric oxide synthase (NOS)-NO system, a negative modulator of glucose-st...

2015
Tonguç Utku Yilmaz Nuray Yazihan Aydın Dalgic Ezgi Ermis Kaya Bulent Salman Mehtap Kocak Ethem Akcil

BACKGROUND & OBJECTIVES Erythropoietin (EPO) has cytoprotective and anti-apoptotic effects in pathological conditions, including hypoxia and ischaemia-reperfusion injury. One of the targets to protect against injury is ATP-dependent potassium (KATP ) channels. These channels could be involved in EPO induced ischaemic preconditoning like a protective effect. We evaluated the cell cytoprotective ...

Journal: :Circulation research 1991
J R McCullough D E Normandin M L Conder P G Sleph S Dzwonczyk G J Grover

The potassium channel activators cromakalim and pinacidil were recently shown to have anti-ischemic properties in isolated globally ischemic rat hearts. The effects of two reported blockers of ATP-sensitive potassium channels, glibenclamide (glyburide) and sodium 5-hydroxydecanoate, on the anti-ischemic efficacy of cromakalim were determined in this model. Buffer-perfused rat hearts were subjec...

Journal: :European Journal of Clinical Pharmacology 1991

2016
Virendra Rambiritch Poobalan Naidoo Breminand Maharaj Goonaseelan Pillai

AIM The aim of this study was to describe the pharmacokinetics (PK) of glibenclamide in poorly controlled South African type 2 diabetic subjects using noncompartmental and model-based methods. METHODS A total of 24 subjects with type 2 diabetes were administered increasing doses (0 mg/d, 2.5 mg/d, 5 mg/d, 10 mg/d, and 20 mg/d) of glibenclamide daily at 2-week intervals. Plasma glibenclamide, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید